Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

被引:384
作者
Arnsten, JH
Demas, PA
Grant, RW
Gourevitch, MN
Farzodegan, H
Howard, AA
Schoenboum, EE
机构
[1] Montefiore Med Ctr, AIDS Res Program, Dept Epidemiol & Social Med, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, Div Subst Abuse, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
adherence; drug users; antiretroviral therapy; electronic monitors;
D O I
10.1007/s11606-002-0044-3
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Despite a burgeoning literature on adherence to HIV therapies, few studies have examined the impact of ongoing drug use on adherence and viral suppression, and none of these have utilized electronic monitors to quantify adherence among drug users. We used 262 electronic monitors to measure adherence with all antiretrovirals in 85 HIV-infected current and former drug users, and found that active cocaine use, female gender, not receiving Social Security benefits, not being married, screening positive for depression, and the tendency to use alcohol or drugs to cope with stress were all significantly associated with poor adherence. The strongest predictor of poor adherence and, in turn, failure to maintain viral suppression, was active cocaine use. Overall adherence among active cocaine users was 27%, compared to 68% among subjects who reported no cocaine use during the 6-month study period. Consequently, 13% of active cocaine users maintained viral suppression, compared to 46% of nonusers. Interventions to Improve adherence should focus on reducing cocaine use, developing adaptive coping skills, and identifying and treating depression.
引用
收藏
页码:377 / 381
页数:5
相关论文
共 20 条
[1]
Avants SK, 2001, AM J ADDICTION, V10, P69
[2]
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[3]
ASSESSING COPING STRATEGIES - A THEORETICALLY BASED APPROACH [J].
CARVER, CS ;
SCHEIER, MF ;
WEINTRAUB, JK .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1989, 56 (02) :267-283
[4]
*CDCP, 2000, HIV AIDS SURV REP, V12
[5]
Time to initiating highly active antiretroviral therapy among HIV infected injection drug users [J].
Celentano, DD ;
Galai, N ;
Sethi, AK ;
Shah, NG ;
Strathdee, SA ;
Vlahov, D ;
Gallant, JE .
AIDS, 2001, 15 (13) :1707-1715
[6]
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments [J].
Chesney, MA ;
Ickovics, JR ;
Chambers, DB ;
Gifford, AL ;
Neidig, J ;
Zwickl, B ;
Wu, AW .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03) :255-266
[7]
Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386
[8]
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy [J].
Gordillo, V ;
del Amo, J ;
Soriano, V ;
González-Lahoz, J .
AIDS, 1999, 13 (13) :1763-1769
[9]
The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response [J].
Haubrich, RH ;
Little, SJ ;
Currier, JS ;
Forthal, DN ;
Kemper, CA ;
Beall, GN ;
Johnson, D ;
Dubé, MP ;
Hwang, JY ;
McCutchan, JA .
AIDS, 1999, 13 (09) :1099-1107
[10]
Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial [J].
Kastrissios, H ;
Suárez, JR ;
Katzenstein, D ;
Girard, P ;
Sheiner, LB ;
Blaschke, TF .
AIDS, 1998, 12 (17) :2295-2303